Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor

被引:257
|
作者
Chi, EY
Krishnan, S
Kendrick, BS
Chang, BS
Carpenter, JF
Randolph, TW
机构
[1] Univ Colorado, Dept Chem Engn, Ctr Pharmaceut Biotechnol, ECCH 111, Boulder, CO 80309 USA
[2] Amgen Inc, Amgen Ctr, Thousand Oaks, CA 91320 USA
[3] Amgen Inc, Longmont, CO 80503 USA
[4] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Denver, CO 80262 USA
关键词
non-native protein aggregation; rhGCSF; protein stability; protein formulation strategy; osmotic second virial coefficient; light scattering; protein interactions; activation energy;
D O I
10.1110/ps.0235703
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We studied the non-native aggregation of recombinant human granulocyte stimulating factor (rhGCSF) in solution conditions where native rhGCSF is both conformationally stable compared to its unfolded state and at concentrations well below its solubility limit. Aggregation of rhGCSF first involves the perturbation of its native structure to form a structurally expanded transition state, followed by assembly process to form an irreversible aggregate. The energy barriers of the two steps are reflected in the experimentally measured values of free energy of unfolding (DeltaG(unf)) and osmotic second virial coefficient (B-22), respectively. Under solution conditions where rhGCSF conformational stability dominates (i.e., large DeltaG(unf) and negative B-22), the first step is rate-limiting, and increasing DeltaG(unf) (e.g., by the addition of sucrose) decreases aggregation. In solutions where colloidal stability is high (i.e., large and positive B-22 values) the second step is rate-limiting, and solution conditions (e.g., low pH and low ionic strength) that increase repulsive interactions between protein molecules are effective at reducing aggregation. rhGCSF aggregation is thus controlled by both conformational stability and colloidal stability, and depending on the solution conditions, either could be rate-limiting.
引用
收藏
页码:903 / 913
页数:11
相关论文
共 50 条
  • [1] Efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in neutropenic children with malignancies
    Lydaki, E
    Bolonaki, E
    Stiakaki, E
    Dimitriou, H
    Kambourakis, A
    Kalmantis, T
    Kalmanti, M
    [J]. BLOOD, 1995, 86 (10) : 2785 - 2785
  • [2] CLINICAL-EXPERIENCE WITH RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR AND GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR
    MORSTYN, G
    LIESCHKE, GJ
    SHERIDAN, W
    LAYTON, J
    CEBON, J
    FOX, RM
    [J]. SEMINARS IN HEMATOLOGY, 1989, 26 (02) : 9 - 13
  • [3] Reengineering granulocyte colony-stimulating factor for enhanced stability
    Bishop, B
    Koay, DC
    Sartorelli, AC
    Regan, L
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (36) : 33465 - 33470
  • [4] Effect of backbone circularization on colloidal stability: Compaction of unfolded structures improves aggregation resistance of granulocyte colony-stimulating factor
    Shibuya, Risa
    Miyafusa, Takamitsu
    Imamura, Hiroshi
    Ooishi, Ayako
    Honda, Shinya
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 605
  • [5] CLINICAL EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR
    TESHIMA, H
    SHIBATA, H
    HIRAOKA, A
    NAKAMURA, H
    MASAOKA, T
    TAKAKU, F
    [J]. EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 520 - 520
  • [6] Pharmacokinetics and pharmacodynamics of a recombinant human granulocyte colony-stimulating factor
    Kuwabara, T
    Kobayashi, S
    Sugiyama, Y
    [J]. DRUG METABOLISM REVIEWS, 1996, 28 (04) : 625 - 658
  • [7] CHEMOTACTIC ACTIVITY OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR
    WANG, JM
    CHEN, ZG
    COLELLA, S
    BONILLA, MA
    WELTE, K
    MANTOVANI, A
    BORDIGNON, C
    [J]. BLOOD, 1988, 72 (05) : 1456 - 1460
  • [8] PHARMACOKINETICS OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN MICE
    TANAKA, H
    KANEKO, T
    [J]. BLOOD, 1992, 79 (02) : 536 - 537
  • [9] Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants
    Ahmad, A
    Laborada, G
    Bussel, J
    Nesin, MJ
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (11) : 1061 - 1065
  • [10] EFFECT OF HUMAN RECOMBINANT GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR AND NATIVE GRANULOCYTE COLONY-STIMULATING FACTOR ON CLONOGENIC LEUKEMIC BLAST CELLS
    ASANO, Y
    SHIBUYA, T
    OKAMURA, S
    YAMAGA, S
    OTSUKA, T
    NIHO, Y
    [J]. CANCER RESEARCH, 1987, 47 (21) : 5647 - 5648